Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment

Clinical trial NCT02581592 · COMPLETED

Trial details

NCT number: NCT02581592
Sponsor: Mylan Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2015-11-01
Primary completion: 2016-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.